“…Taken together, the majority of the available in vivo data clearly suggest an excitatory effect of dopamine on STN neurons that is mediated via dopamine D1 receptors. DA Campbell et al, 1985Hassani et al, 1999DA Zhu et al, 2002aZhu et al, 2002bD2 -quinpirole Zhu et al, 2002aTofighy et al, 2003 D1/D5-SKF82958;SKF 81297 Baufreton et al, 2003DA Zhu et al, 2002bD2 -quinpirole Zhu et al, 2002a 2005 D1/D5-SKF38393 ; SKF82958; SKF 81297 Baufreton et al, 2005Loucif et al, 2008 In Vivo DA Campbell et al, 1985amphetamine Welchsler et al,1979 D1/D2 -apomorphine Brown et al, 1978Hassani et al, 1999 D1/D5 -SKF82958 Hassani et al, 1999D2 -quinpirole Hassani et al, 1999DA Mintz et al, 1986Ni et al, 2001 D1/D2 -apomorphine Trugmann et al,1993Kreiss et al, 1996 D1/D5-SKF38393 ; SKF82958 Ni et al, 2001Kreiss et al, 1996 D1/D5 -SKF82958 Hassani et al, 1999DA Ni et al, 2001 D2 -quinpirole Hassani et al, 1999Ni et al, 2001 D1/D5- SKF38393 Ni et al, 2001 Table 1. Overview of different publications regarding the effects of dopamine and its agonists on subthalamic activity in both intact and 6-OHDA lesioned rats.…”